Covid19 News: Hepatitis-C drugs make covid19 treatment possible, claims in this new study
Hepatitis-C medicines are effective in the treatment of coronavirus. This has been claimed in a study published in the science journal called Structures. Scientists at the US Department of Energy found in the study that hepatitis-C drugs contained a special enzyme that had the ability to prevent the coronavirus from increasing its numbers in human cells.
The study was conducted at the Oak Ridge National Laboratory of the US Department of Energy. Research has found that the main protease of the coronavirus can be destroyed by Hepatitis-C medicine. Protease is an important protein enzyme that gives reproduction power to the coronavirus.
Researchers say that to prevent the coronavirus from spreading, it is necessary that the proteases present in it be prevented from functioning. The lead author Daniel Neller states that we found that hepatitis-C drugs inhibit and inhibit the coronavirus protease.
The lead author, Daniel Neller, said that there is no current approval by the US Food and Drug Administration (FDA) that targets the main protease of the SARS-Cove-2 virus. This research, he says, is the first step in determining whether these drugs should be considered as useful candidates in the treatment of Covid19.